MARKET

CVAC

CVAC

Curevac B.V.
NASDAQ
2.570
-0.095
-3.56%
After Hours: 2.730 +0.16 +6.23% 19:58 04/17 EDT
OPEN
2.700
PREV CLOSE
2.665
HIGH
2.729
LOW
2.540
VOLUME
921.44K
TURNOVER
0
52 WEEK HIGH
12.36
52 WEEK LOW
2.540
MARKET CAP
575.48M
P/E (TTM)
-1.7534
1D
5D
1M
3M
1Y
5Y
CVAC, SBNY and CRMD are among after hour movers
On the Move CVAC, SBNY and CRMD are among after hour movers. Vanda Pharmaceuticals and Sutro Biopharma are among the companies to gain. Eton Pharmaceuticals, Leslie's and Signature Bank are among those to lose. The day's top 10 stocks.
Seeking Alpha · 4h ago
CureVac Partners with MD Anderson on Cancer Vaccines
TipRanks · 1d ago
CureVac, MD Anderson teams up for cancer vaccines
CureVac and the University of Texas MD Anderson Cancer Center announced a co-development and licensing pact to develop cancer vaccines. Both parties will work on identifying differentiated cancer antigens. CureVac will retain worldwide exclusive rights to late-stage development, commercialization of cancer vaccine candidates.
Seeking Alpha · 1d ago
BRIEF-Curevac And MD Anderson To Cooperate On Developing Novel Cancer Vaccines
Curevac and MD Anderson To Cooperate On Developing Novel Cancer Vaccines. CureVac aims to develop vaccines in select cancers with high unmet medical need. The two companies will work together to develop the vaccines. The company is based in Germany.
Reuters · 1d ago
CUREVAC AND MD ANDERSON ENTER STRATEGIC COLLABORATION TO DEVELOP NOVEL CANCER VACCINES
Reuters · 1d ago
Weekly Report: what happened at CVAC last week (0408-0412)?
Weekly Report · 2d ago
Weekly Report: what happened at CVAC last week (0401-0405)?
Weekly Report · 04/08 10:37
Leerink Partners Keeps Their Buy Rating on CureVac (CVAC)
TipRanks · 04/08 07:27
More
About CVAC
CureVac AG is a clinical-stage biopharmaceutical company, The Company strives to create transformative medicines to protect and improve people’s lives. Fueled by proprietary RNA technology platform combined with two decades of science and manufacturing, The Company is dedicated to creating novel treatments that enable the body to make its own prophylactic and therapeutic drugs.

Webull offers CureVac BV stock information, including NASDAQ: CVAC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CVAC stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CVAC stock methods without spending real money on the virtual paper trading platform.